CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$1.19−0.12 (-9.16%)

Close on Nov 12, 2026Market cap $20.93MP/E –Yield –

Cel Sci gross margin

Gross margin is gross profit as a percentage of revenue.

Cel Sci has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?